Novo Nordisk Says New Obesity Drug Helps Patients Lose Weight in Mid-Stage Trial

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Novo Nordisk’s weight-loss-drug trial provides rare good news in a rocky year

Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in ...

New weight-loss shot shows major fat reduction, but experts urge caution

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...
HealthDay on MSN

GLP-1 Weight-Loss Drug in Pill Form Shows Promise in Trial

Key Takeaways Current GLP-1 weight-loss meds need to be taken as injections, but new trial results suggest a GLP-1 in pill ...

Novo Nordisk's obesity drug shows weight loss of up to 14.5% in mid-stage study

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study.

Weight-Loss Drugs Don’t Appear to Work Against Alzheimer’s

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...
SHEfinds on MSN

Ariana Grande Fans ‘Worried’ After Noticing Her Weight Loss During Wicked: For Good Promo Appearance

Ariana Grande Red Carpet Grabber Deported, Banned From Singapore Six-figure earners are ‘living the illusion of affluence’ ...

Voting Results: Mason Coleman named The Sporting News Louisiana high school football performer from Week 1 of the playoffs (Nov. 10-16)

Mason Coleman had a huge night on defense for his team in its opening-round playoff game. A junior defensive ...